Related Experiment Video
Updated: Jun 28, 2025
09:48
Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
4.3K
The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast
Andrea Pagani1, Dominik Duscher1, Sebastian Geis1
1Department of Plastic, Hand and Reconstructive Surgery, University Hospital Regensburg, Franz-Josef-Strauß Allee 11, 93053 Regensburg, Germany.
Cells
|April 12, 2024
Summary
Adipose-Derived Stem Cell Exosomes show promise for treating triple-negative breast cancer by targeting tumor cells and their microenvironment. Further research is needed to translate these findings from lab studies to clinical applications.
Area of Science:
- Cell biology
- Biomedical engineering
- Oncology
Background:
- Extracellular vesicles (EVs) mediate intercellular communication, exchanging biological information between cells.
- Exosomes, a subtype of EVs, possess unique properties for clinical and therapeutic applications.
- Breast cancer involves complex interactions between tumor cells and their microenvironment, driving growth and metastasis.
Purpose of the Study:
- To review literature on EVs and Adipose-Derived Stem Cell Exosomes (ADSC-Exosomes) in breast cancer.
- To explore the biological properties and therapeutic potential of ADSC-Exosomes, particularly for triple-negative breast cancer (TNBC).
Main Methods:
- Literature review of significant PubMed publications.
- Focus on studies concerning extracellular vesicles, ADSC-Exosomes, and breast cancer.
Main Results:
- ADSC-Exosomes can target TNBC cells at multiple levels: tumor core, microenvironment, and metastases.
- Engineered ADSC-Exosomes demonstrate potential for impacting TNBC progression.
Conclusions:
- ADSC-Exosomes offer a potential therapeutic strategy for TNBC.
- Translating in vitro findings to in vivo applications presents a significant challenge.
